A β-Galactosidase-Activated Fluorogenic Reporter for the Detection of Gastric Cancer In Vivo and in Urine-Reference-Cited by-同舟云学术

A β-Galactosidase-Activated Fluorogenic Reporter for the Detection of Gastric Cancer In Vivo and in Urine

Published:2024-04-12 Issue:16 Volume:96 Page:6390-6397
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Yu Mengya¹,Meng Zhenqi¹,Yi Shujuan²³,Chen Jianjiao¹,Xu Weiping²³,Ruan Bankang²³,Wang Junjian²³,Han Fanghai¹,Huang Jiaguo²³^ORCID

Affiliation:

1. Department of Gastrointestinal Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510120, China

2. School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China

3. National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-Sen University, Guangzhou 510006, China

Funder

Sun Yat-sen University

Key Technologies Research and Development Program of Guangzhou Municipality

National Key Research and Development Program of China

Basic and Applied Basic Research Foundation of Guangdong Province

Guangdong Provincial Pearl River Talents Program

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Recruitment Program of Global Experts

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.4c00429

Reference53 articles.

1. Gastric cancer

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017

4. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

5. Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer